Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition. Mol Cell Biochem 2005 Feb;270(1-2):1-11
Date
03/29/2005Pubmed ID
15792348DOI
10.1007/s11010-005-2540-3Scopus ID
2-s2.0-15844380045 (requires institutional sign-in at Scopus site) 42 CitationsAbstract
Myocardial ischemia-reperfusion (I/R) is associated with the activation of matrix metalloproteinases (MMPs) and serine proteases. We hypothesized that activation of MMPs and the serine protease plasmin contribute to early cardiac myocyte death following I/R and that broad-spectrum protease inhibition with doxycycline (DOX) preserves myocyte viability. Rats treated daily with or without DOX beginning 48 h prior to experimentation were subjected to 30 min of coronary occlusion and 2 days of reperfusion. DOX pre-treatment reduced infarct size by 37%. DOX attenuated increases in MMP-9 and plasmin levels as determined by gelatin zymography and immunoblot, respectively. Neutrophil extravasation was unaltered by DOX as assessed by myeloperoxidase (MPO) activity. To examine the contribution of MMP-9 and plasmin to myocyte injury, cultures of neonatal rat ventricular myocytes (NRVMs) were treated for 48 h with 83 kDa MMP-9 or plasminogen in the presence or absence of DOX. MMP-9 treatment did not affect myocyte viability. Plasminogen treatment led to increased plasmin activity, resulting in loss of beta1-integrin, NRVM detachment and apoptosis. DOX co-treatment inhibited plasmin activity and preserved NRVM attachment, whereas co-treatment with the broad-spectrum MMP inhibitor GM6001 had no effect. These results indicate that plasmin causes disruption of myocyte attachment and viability independently of MMP activation in vitro and that inhibition of plasmin by DOX may reduce I/R-induced myocyte death in vivo through the inhibition of plasmin.
Author List
Griffin MO, Jinno M, Miles LA, Villarreal FJAuthor
Michael O. Griffin MD, PhD Associate Professor in the Radiology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsAnimals, Newborn
Annexin A5
Anti-Bacterial Agents
Apoptosis
Cells, Cultured
Dose-Response Relationship, Drug
Doxycycline
Fibrinolysin
Humans
Immunoblotting
Inflammation
Integrin beta1
Male
Matrix Metalloproteinase 9
Microscopy, Phase-Contrast
Myocardial Infarction
Myocardial Ischemia
Myocardial Reperfusion
Myocardium
Peroxidase
Rats
Rats, Sprague-Dawley
Reperfusion Injury
Time Factors
Up-Regulation